Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Kalamazoo, USA
4717 Campus Drive
Suite 1100
Kalamazoo, MI, 49008
USA

People

President and CEO

Funding

TOTAL $13.7M
FUNDING TOTAL $13.7M
Partial Close, 12/2010
$1.69M
Series C, 1/2014
Capital Midwest Fund
$12M
DEBT TOTAL $4.3M
Debt, 6/2013
$4.3M

Tags

ProNAi Therapeutics

ProNAi Therapeutics, Inc. is a DNA Interference (DNAi®)-based biopharmaceutical company that is leveraging its novel and proprietary nucleic acid-based interfering technology, DNAi®, to advance a next generation of therapies for patients with cancer and other complex genetic diseases.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. ProNAi Therapeutics Raises $12M in Series C Financing (finsmes.com) [edit]
Edit This Page
Last Edited 1/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy